Skip to main content

Table 2 Association between baseline clinical factors and changes in either BCVA or CRT at week 24

From: Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab

 

Change in BVCA

Change in CRT

Correlation coefficient

P value

Correlation coefficient

P value

Age

−0.063

0.555

−0.013

0.903

duration of DM

0.090

0.394

0.139

0.189

SBP

0.018

0.864

−0.146

0.166

DBP

−0.012

0.913

−0.018

0.867

HbA1c

0.021

0.845

0.138

0.191

TC

0.027

0.800

0.148

0.161

TG

0.027

0.797

0.044

0.681

HDL

−0.072

0.499

0.016

0.880

LDL

−0.085

0.426

0.078

0.462

Scr

0.157

0.137

−0.006

0.953

BUN

0.054

0.610

−0.089

0.401

Baseline BCVA

−0.305

0.003

0.046

0.662

Baseline CRT

0.275

0.008

0.170

0.107

WBC

−0.166

0.115

−0.037

0.729

Neutrophils

−0.383

< 0.001

0.061

0.564

Monocytes

−0.074

0.486

0.031

0.770

Platelets

−0.024

0.819

0.017

0.871

Lymphocytes

0.399

< 0.001

−0.062

0.559

NLR

−0.660

< 0.001

0.130

0.218

MLR

−0.392

< 0.001

0.058

0.585

PLR

−0.335

0.001

0.045

0.670

  1. DM diabetes mellitus, SBP systolic blood pressure, DBP diastolic blood pressure, WBC white blood cell, HbA1c Hemoglobin A1c, TC total cholesterol, TG triglycerides, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, Scr serum creatinine, BUN blood urea nitrogen, BCVA best-corrected visual acuity, CRT central retinal thickness, WBC white blood cell, NLR neutrophil-to-lymphocyte ratio, MLR monocyte-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio.
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us